BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. (BCRX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BCRX · as of Jun 8, 2026
Key Statistics
Explore BioCryst Pharmaceuticals, Inc. Data
bcrx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 29 · Buy rate: 86.2%
The BCRX analyst consensus is Buy, based on ratings from 29 Wall Street analysts over the past 3 months. The average 12-month price target is $16.86, representing +102.04% upside from the current price of $8.35.
Competitors & Peers
bcrx competitorsBCRX
ARDX
MAZE
NTLA
PHVS
STOKStock Performance
Full HistoryAbout BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the tr…
what is biocryst pharmaceuticals, inc. · bcrx stock overview · biocryst pharmaceuticals, inc. company profile · who is biocryst pharmaceuticals, inc. ceo · bcrx NASDAQ · biocryst pharmaceuticals, inc. headquarters · biocryst pharmaceuticals, inc. business segments
About Stock Overview & Key Data
BioCryst Pharmaceuticals, Inc. (BCRX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 4, 1994. As of the latest trading session, BCRX stock price is $8.35, with a market capitalization of $1.8B. The stock has returned -24.86% over the past 12 months and +7.02% year-to-date.
According to 29 Wall Street analysts, the consensus rating for BioCryst Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $16.86. In fiscal year 2025, BioCryst Pharmaceuticals, Inc. reported revenue of $874.8M and net income of $263.9M. For detailed data — including BioCryst Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, BioCryst Pharmaceuticals, Inc. (BCRX) stock price is $8.35. The stock is traded on NASDAQ under the ticker symbol BCRX. The 52-week range is $6.00 – $11.23.